Countries in the WHO European Region and their status regarding gonococcal antimicrobial resistance (AMR) surveillance
| European Union (EU) countries | European Economic Area (EEA) countries | Non-EU/EEA countries |
|---|---|---|
| Austria | Iceland | Albania |
| Belgium | Liechtenstein* | Andorra |
| Bulgaria | Norway | Armenia† |
| Cyprus | Azerbaijan† | |
| Czech Republic | Belarus | |
| Croatia | Bosnia and Herzegovina | |
| Denmark | Georgia† | |
| Estonia | Israel | |
| Finland | Kazakhstan† | |
| France | Kyrgyzstan | |
| Germany | Monaco | |
| Greece | Montenegro | |
| Hungary | Republic of Moldova† | |
| Ireland | Russian Federation | |
| Italy | San Marino | |
| Latvia | Serbia | |
| Lithuania | Switzerland | |
| Luxembourg | Tajikistan† | |
| Malta | The former Yugoslav Republic of Macedonia | |
| The Netherlands | Turkey | |
| Poland | Turkmenistan | |
| Portugal | Ukraine† | |
| Romania | Uzbekistan† | |
| Slovakia | ||
| Slovenia | ||
| Spain | ||
| Sweden | ||
| UK |
Bold underlined letters: countries (n = 21) included in the European Gonococcal Antimicrobial Surveillance Programme (Euro-GASP) that is funded and coordinated by the European Centre for Disease Prevention and Control (ECDC).
Bold letters: countries (n=5) with AMR data, quality assured according to WHO standards, internationally available during the last year(s).
*Liechtenstein is not included in the WHO European Region, however, is one of the three EEA countries.
†Countries that have been surveyed and had professionals trained in quality assured gonococcal culture and AMR testing, according to WHO standards, but AMR data are still not available.